Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Electrical Stimulation for the Treatment of Glaucoma

NCT: NCT05626491 · ACTIVE_NOT_RECRUITING

NCT IDNCT05626491
StatusACTIVE_NOT_RECRUITING
Start Date2023-02-28
Completion2026-12

Brief Summary

The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.

Frequently Asked Questions

What is Electrical Stimulation for the Treatment of Glaucoma?

Electrical Stimulation for the Treatment of Glaucoma is a clinical trial registered under NCT05626491. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05626491?

The current status of NCT05626491 (Electrical Stimulation for the Treatment of Glaucoma) is: ACTIVE_NOT_RECRUITING.

When did Electrical Stimulation for the Treatment of Glaucoma start?

Electrical Stimulation for the Treatment of Glaucoma started on 2023-02-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑